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Abstract. Phlebotomus papatasi sand flies are among the primary vectors of Leishmania major parasites from
Morocco to the Indian subcontinent and from southern Europe to central and eastern Africa. Antibody-based immunity
to sand fly salivary gland proteins in human populations remains a complex contextual problem that is not yet fully
understood. We profiled the immunoreactivities of plasma antibodies to sand fly salivary gland sonicates (SGSs) from
229 human blood donors residing in different regions of sand fly endemicity throughout Jordan and Egypt as well as
69 US military personnel, who were differentially exposed to P. papatasi bites and L. major infections in Iraq. Compared
with plasma from control region donors, antibodies were significantly immunoreactive to five salivary proteins (12, 26,
30, 38, and 44 kDa) among Jordanian and Egyptian donors, with immunoglobulin G4 being the dominant anti-SGS
isotype. US personnel were significantly immunoreactive to only two salivary proteins (38 and 14 kDa). Using k-means
clustering, donors were segregated into four clusters distinguished by unique immunoreactivity profiles to varying
combinations of the significantly immunogenic salivary proteins. SGS-induced cellular proliferation was diminished
among donors residing in sand fly-endemic regions. These data provide a clearer picture of human immune responses to
sand fly vector salivary constituents.
INTRODUCTION
The causative agents of leishmaniasis are protozoan para-
sites of the genus Leishmania. All species within the genus
share a common lifecycle that involves an extracellular infec-
tive stage present in the sand fly vector followed by an intra-
cellular stage of replication within a vertebrate host. Estimates
of annual global disease incidence are approximately 0.2–
0.4 and 0.7–1.2 million cases of active visceral and cutaneous
leishmaniasis, respectively.1 Leishmaniasis is primarily found in
tropical and subtropical regions, where vector-competent sand
fly species of the family Psychodidae reside. Medically relevant
genera of the sand fly subfamily Phlebotominae are distin-
guished by distinct geographical regions of endemicity:
Phlebotomus in the Old World (the Mediterranean, Middle
East, and Africa) and Lutzomyia in the New World (Central
and South America).2
Currently, no efficacious vaccine exists to combat infection
or transmission of Leishmania. In lieu of a vaccine directed at
the parasites, attention has focused on another aspect of the
disease cycle: the sand fly vector. One hypothesis is that,
through pre-exposure to sand fly vector salivary components,
individuals are immunized to establish a robust immunologi-
cal memory against vector salivary factors. This response may
generate a hostile microenvironment for parasite transmission
on reexposure. For every species of Leishmania parasite, only
a few sand fly species are capable of vectoring a specific
Leishmania species,3 resulting in a very restrictive and unique
vector–parasite exposure profile. Key to the downstream
development of a vaccine is the careful examination of host
immunological responses to vector salivary proteins among
persons naturally pre-exposed to sand fly bites.4,5
Many studies have sought to investigate the serological
markers of hosts, both animal and human, against sand fly
species,6–14 although the problem remains a highly complex
and contextual matter warranting deeper novel analysis. To
better characterize acquired human host immune responses to
sand fly saliva, we collected peripheral blood samples from
229 people who reside in Middle Eastern regions (Egypt and
Jordan) of variable endemic disease ecologies for cutaneous
leishmaniasis and its predominant Old World vector, the sand
fly P. papatasi. Additionally, samples were collected from
69 US military personnel, differentially exposed to P. papatasi
bites and L. major infections, to aid in comparisons with immu-
nologically naı¨ve individuals. Our work sought to understand
host population variation with reference to antivector saliva
immunity and identify salivary proteins for later investigation
as potential exposure markers.
METHODS
Study sites and human peripheral blood donors. Six sites in
the Middle East and North Africa (MENA) were chosen for
collection of 229 human peripheral blood samples during late
August and early September of 2007. Table 1 shows regional
donor profiles. Geospatial coordinates for these regions were
as previously described.15 Each site was selected based on eco-
logical characteristics in Jordan16–23 and Egypt24–29 pertaining
to active cases of leishmaniasis transmission and the presence
of P. papatasi vectors. These sites included Cairo (CA), Egypt
and Amman (AM), Jordan (a lack of sand fly vectors); Aswan
(AW), Egypt and Malka (MA), Jordan (regions of endemic P.
papatasi populations but that lack clinical reports of L. major
infections); and North Sinai (NS), Egypt and Swaymeh (SW),
Jordan (regions of endemic P. papatasi population as well as
regions with reports of active L. major transmission). Blood
samples from regional Egyptian and Jordanian donors were
drawn from healthy adults, none of whom presented with
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active lesions. Peripheral blood samples were similarly col-
lected from 69 US military personnel at Walter Reed Army
Medical Center, Washington, DC. US donors were interviewed
for histories of suspected sand fly bite exposure or presented
with clinically confirmed cases of cutaneous leishmaniasis but were
untreated before blood sampling. All donors were ³ 18 years
of age, and the number of male and female participants was
approximately equal. All donors signed documents of informed
consent per local and US laws, and samples were stripped of all
personal identifying information before processing.
Human host blood collection. Ten to fifteen milliliters
blood were collected in yellow top Vacutainer blood collec-
tion tubes with ACD solution A anticoagulant (BD Biosci-
ences, San Jose, CA). Tubes were kept at 4°C and centrifuged
at 3,000 rpm for 10 minutes. The aqueous top plasma layer
was removed and stored at −20°C. Remaining mixed leuko-
cytes and red blood cells were segregated using Lymphocyte
Separation Media (Cellgro, Manassas, VA) following the man-
ufacturer’s protocol. Remaining cells were suspended in red
blood cell lysis buffer (0.15 M ammonium chloride, 10 mM
potassium bicarbonate, and 0.1 mM (ethylenedinitrilo)
tetraacetic acid [EDTA]), incubated for 5 minutes on ice,
washed with 1 + phosphate buffered saline (PBS; 137 mM
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, and 1.8 mM KH2PO4),
and resuspended in standard RPMI-1640 media (Cellgro) sup-
plemented with 10% fetal bovine serum (FBS), 100 U/mL
penicillin, 100 mg/mL streptomycin, and 2 mM L-glutamine
(referred to as RPMI-C). Mixed cells in RPMI-C media were
combined 1:1 in freezing media (20% dimethyl sulfoxide
[DMSO], 20% FBS, and 60% RPMI-C), slow frozen overnight
at −80°C in an isopropanol chamber, transferred to dry ice for
transport, and ultimately transferred to liquid nitrogen for
long-term storage before use in cell proliferative assays.
Sand f ly colony. P. papatasi sand flies used in this study
were derived from the Israeli strain maintained at the Labo-
ratory of Malaria and Vector Research, National Institutes of
Health (Rockville, MD) and the University of Notre Dame
(Notre Dame, IN) as previously described.15
Salivary gland sonicates. Salivary glands from 1- to 2-week-
old unfed female P. papatasi sand flies were dissected intact
under 1 + PBS and flash frozen at −80°C for storage. To pro-
cure salivary gland protein sonicates (SGSs), salivary glands
were subjected to three cycles of rapid freeze–thaw (−80°C for
2 minutes and then a 37°Cwater bath for 1 minute), centrifuged
for 1 minute at 14,000 rpm, sonicated in a room temperature
water bath for 1 minute at 80% power using an Ultrasonic
Processor (Cole Parmer, Vernon Hills, IL), and then, filter-
sterilized by centrifugation at 14,000 rpm for 1 minute through
a 0.22-mm Ultrafree centrifugal filter unit (Millipore, Billerica,
MA). Total protein quantities were assessed by standard curve
to bovine serum albumin dilutions using the Protein A280
feature of a NanoDrop 1000 microvolume UV-Vis spectropho-
tometer (Thermo Scientific, Waltham, MA). A whole-salivary
gland equivalent concentration was considered approximately
1.5 mg based on estimates of complete lobe pairs from sugar-fed
female Lu. longipalpis salivary gland protein concentrations.30
Mass spectrometry and protein sequence alignments.
Twenty salivary gland protein equivalents from P. papatasi
SGS in 1 + PBS were boiled at 85°C for 5 minutes with
Tris-glycine sodium dodecyl sulfate (SDS) sample buffer and
NuPAGE reducing agent (Novex, Carlsbad, CA). Samples
were applied to a pre-cast 4–20% stacking Tris-glycine gel
(Novex) with a PageRuler pre-stained protein ladder
(Fermentas, Pittsburgh, PA) on the side and electrophoresed
at 125 V for 90 minutes. Salivary proteins were run in single
dimension electrophoresis to allow cross-comparison with
immunoblots. The gel was bathed in fixation solution (50%
methanol and 10% acetic acid) overnight and then stained for
4 hours in 1% Coomassie Blue R-250 (Bio-Rad, Hercules,
CA). The gel was destained overnight in destaining solution
(5% methanol and 7.5% acetic acid) and stored in 7% acetic
acid for imaging on a gel doc Universal Hood II (Bio-Rad,
Hercules, CA). Ten intensely stained protein gel bands were
cut precisely using clean, sterile scalpels. Gel slices were pre-
pared by trypsin digestion for mass spectrometry (MS) as pre-
viously described.31 Samples were desalted by Ziptip
(Millipore, Billerica, MA) before liquid chromatography (LC)
/MS/MS analysis performed on a 5500QTrap operating in ion-
trap mode (ABSciex, Farmingham, MA) connected to an
Eksigent (AB Sciex) NanoUltra UHPLC system. Samples were
acquired as described.32 Briefly, each gel band was analyzed in
technical duplicate and separated over a gradient from 2% to
35% acetonitrile (0.1% formic acid) on a 100-mm + 100-mm
C18BEH column (Waters, Milford, MA) running at 600 nL/
min for 1 hour. A TOP8 data-dependent method was used for
spectral acquisition. Peak lists were subjected to database
search against all available Phlebotomus and Lutzomyia spp.
protein sequences available through the US National Center
for Biotechnology Information (NCBI)33 combined with a list
of common contaminants (e.g., trypsin, keratin, etc.). False
Table 1
Summary of human peripheral blood donors
Abbreviation Country P. papatasi endemicity* L. major transmission reports* Number of blood donors
MENA sites†
Cairo CA Egypt − − 37
Aswan AW Egypt + − 40
North Sinai NS Egypt + + 34
Amman AM Jordan − − 37
Malka MA Jordan + − 41
Swaymeh SW Jordan + + 40
US military‡ P. papatasi bite exposure§ L. major infection§
Control United States − − 29
Bitten United States + − 17
Infected United States + + 23
*Marks indicate the presence (+) or absence (−) of endemic P. papatasi populations and known cases of active L. major transmission in the region.
†MENA locations in which human peripheral blood donors resided.
‡The condition of US military personnel stationed in the United States (control) or deployed in Iraq (bitten and infected) during 2007.
§Marks indicate yes (+) or no (−) as to whether US military personnel reported exposure to sand fly bites or there was a confirmed diagnosis of cutaneous leishmaniasis while deployed
in Iraq.
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discovery rates (FDRs) were determined by the target–decoy
approach.34 The Paragon algorithm within the Protein Pilot
software suite (AB Sciex, Farmingham, Massachusetts, USA)
was used for database searches,32 and proteins within the
95% FDR interval were chosen for additional analysis. FDR
descriptions for combined protein, peptide, and spectral level
analyses are included in Supplemental Figure 1. Alignment
analyses of published protein sequences were conducted
using Clustal Omega35 or LAlign36 web-based programs with
default settings.
Immunoblots. Western immunoblots to examine human
plasma donor antibodies reactive against SGS were conducted
using a modified version of a previously reported protocol.37
Briefly, 30 SGSs were boiled and separated on pre-cast
10% Tris-glycine SDS–polyacrylamide gel electrophoresis
(PAGE) gels (Novex) with a PageRuler pre-stained protein
ladder (Fermentas) on the side and transferred to nitrocellu-
lose membranes using an XCell II blot module (Novex).
Membranes were blocked for 1 hour at room temperature
(RT) in blocking buffer (0.1% Tween 20/1 + tris-buffered
saline and 5% dried milk), washed three times in 1 +TBS,
and set in a Mini-Protean II multiscreen apparatus (Bio-
Rad). Blood plasma from human donors was diluted 1:100 in
blocking buffer and exposed to the membranes. A single com-
mon donor was exposed to Israeli colony P. papatasi bites 24
hours before blood collection, which served as a normalizing
control on each blot. Membranes and plasma were incubated
overnight at 4°C, washed three times in 1 + TBS, and then,
exposed to a secondary alkaline phosphatase-conjugated goat
anti-human Fc antibody (Zymed, South San Francisco, CA)
diluted 1:5,000 in blocking buffer. Membranes were devel-
oped with colorimetric substrate One Step NPT-BCIP
(Thermo Scientific). Membranes were imaged using a gel doc
Universal Hood II (Bio-Rad). White balance for all images
was normalized to a single immunoblot (Figure 1A) using
Photoshop CS5 software (Adobe, San Jose, CA) to equalize
background intensity. Because of non-specific colorimetric
artifacts in the lanes of many immunoblots, the use of auto-
mated image analysis software, such as ImageJ, to score the
plasma antibody reactivity to SGS protein bands proved
impossible, because a universal baseline was not applicable
to all lanes, even in a single immunoblot. Three people man-
ually scored each blot, and they were independent observers
blinded to the regional identities of the plasma donors applied
to each immunoblot. Observers cataloged the banding pattern
and intensity of each blot based on a numeric scale (0 = no
bands at a given kilodalton value; 1 = low-intensity band; 2 =
moderate-intensity band; 3 = high-intensity band) relative to
the positive control plasma lane appearance. The scores were
combined based on a uniform rule set favoring the majority
opinion at each kilodalton range. The combined score calcu-
lations were checked and verified by each investigator inde-
pendently, providing the most unbiased dataset possible.
Enzyme-Linked Immunosorbent Assay. Isolated SGSs in
1 + PBS were applied at 1.5 mg per well onto a MaxiSorp flat-
bottom 96-well plate (Nunc, Penfield, NY) and incubated
overnight at 4°C. Some wells on each plate were coated
instead with purified human immunoglobulin G (IgG) or IgE
(Abcam, Cambridge, MA) at known concentrations for 1:100,
1:1,000, and 1:10,000 dilutions, which served as standards for
calculations of human donor anti-SGS antibody concentra-
tions. IgG standards (Abcam) were composed of a mixture of
all subclasses (IgG1, −2, −3, and −4) at known percentages of
the total. Plates were washed with 0.05% Tween-20/1 + PBS
and blocked with 5% bovine serum albumin (BSA) in 1 + PBS
for 1 hour at RT. Human plasma in blocking solution was
applied at a 1:100 dilution and incubated overnight at 4°C.
Mouse secondary biotinylated anti-human antibodies, specific
for IgG1, −2, −3, and −4 and IgE isotypes (Sigma-Aldrich,
Saint Louis, MO), were applied at a 1:100 dilution in blocking
Figure 1. Characterization of whole P. papatasi salivary gland protein extract sonicates and human host antibody reactions. (A) Immunoblot
examples of plasma donors from three regions in Egypt and differentially exposed US military personnel with antibody specificity to P. papatasi
salivary proteins. Lanes are designated by regional plasma donor codes (CA, AW, and NS) or differential exposure codes (Con = Control, Bit =
Bitten, and Inf = Infected). (B) Comparison of immunoblot example and whole P. papatasi salivary gland protein sonicate. Lane 2 displays an
immunoblot image of a North Sinai plasma donor with broad antibody specificities to P. papatasi salivary gland proteins. Lane 3 displays a
Coomassie Brilliant Blue R-250-stained P. papatasi whole-salivary gland protein sonicate run on a denaturing SDS-PAGE gel. Lanes 1 and 4 are
PageRuler protein MW ladders (Fermentas).
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buffer, covered from light, and incubated overnight at 4°C.
Plates were incubated with streptavidin-conjugated alkaline
phosphatase (Sigma-Aldrich) diluted 1:500 in TBS-MgCl2/1%
BSA solution for 2 hours at RT and covered from light. After a
final wash, para-nitrophenyl phosphate (pNPP) substrate buffer
(Sigma-Aldrich) was applied, and the plates were incubated for
30 minutes at RT and read at 405 nm on a SpectraMax M2
microplate reader (Molecular Devices, Sunnyvale, CA). IgG
and IgE standards were used to calculate donor anti-SGS anti-
body concentrations by standard curve fitting.
Proliferation assays. Monocytes from cryopreserved mixed
leukocyte samples of human donors were collected by adher-
ence to six-well cell culture plates (Costar, Manassas, VA)
after quick thaws (1 minute in a 37 °C water bath), washing
in RPMI-C media, and a 2-hour incubation at 37°C under
5% CO2. Cells were stimulated every other day for 1 week
with recombinant human granulocyte/macrophage colony-
stimulating factor (GM-CSF; 400 U per 1 + 106 monocytes)
and IL-4 (160 U per 1 + 106 monocytes) to generate monocyte-
derived dendritic cells (MDDCs). Cells were harvested by
repeated washing with 0.5 mM EDTA in 1 + PBS, replated in
a 96-well flat-bottom cell culture plate at a concentration of
4 + 104 MDDCs per well in RPMI-C media, and then, allowed
to rest overnight at 37°C under 5% CO2. Cells were stimulated
with SGS overnight at a concentration of one salivary gland
equivalent (1.5 mg) per well. Negative control wells received
only RPMI-C media, whereas positive control wells received
400 ng phytohemagglutinin (PHA; Sigma-Aldrich) per well.
Mixed leukocytes from the same donors were coincubated
with stimulated MDDCs at a concentration of 8 + 104 per well
at 37°C under 5% CO2 for 4 days; 1 mCi tritiated thymidine
(Perkin-Elmer, Waltham, MA) in RPMI-C was added to each
well for the final 24 hours of coculture. Mixed cultures were
harvested using a scintillation harvester and filter mat paper
(Brandel, Gaithersburg, MD) per the manufacturer’s proto-
col. Scintillation fluid allowed b-particle decay readings on a
Wallac MicroBeta TriLux microplate liquid scintillation
counter (Perkin-Elmer). Final values are reported as the
stimulation index—the ratio of b-counts (3H-thymidine
uptake) between unstimulated and SGS pre-stimulated
MDDCs and mixed leukocyte cocultures.
Luminex cytokine quantification. Culture supernatants
from the proliferation reactions were collected just before
3H-thymidine addition. Supernatants were prepared for quan-
titative cytokine and chemokine fluorescence-based analysis
using a Human Cytokine LINCOplex Premixed 96-well kit
(Millipore, Billerica, MA) following the manufacturer’s pro-
tocols. Plates were read on a Luminex 200 machine, and the
mean fluorescence intensity (MFI) was calculated following
the manufacturer’s protocols for internal normalization. Final
MFI values for each of 21 cytokines or chemokines in super-
natants from each culture exposed in vitro to SGS were sub-
sequently normalized to supernatant values of paired negative
control cultures left unexposed to SGS.
Clustering analysis. K-means clustering was performed
using Cluster v.3.0.38 Data were formatted as sample (plasma
donor) and gene (SGS protein kilodaltons) tables to generate
k = 4 clusters using dataset means measured by Euclidean
distance. Visualization and data export were achieved with
Java Treeview v.1.1.4.39
Statistics. Using GraphPad Prism v.5.0 (Graphpad Software,
San Diego, CA), combined immunoblot scoring data were ana-
lyzed by one-way analysis of variance (ANOVA) and
Bonferroni multiple comparison post-tests performed at each
SGS protein kilodalton for every regional plasma donor
group at a 95% confidence interval. A simple calculation was
used to describe immunogenicity of each salivary protein:
(probability of donor plasma antibody specificity to a particu-
lar salivary protein within a regional sample group) + (aver-
age band intensity among that regional group) = arbitrary
units (a.u.) of immunogenicity between zero and two. The
same software was used to calculate Pearson correlation by
two-tailed distribution using percentages of individuals from
each single region that clustered into the four k-means clusters
as well as Student’s t test comparing regional groups mixed
leukocyte proliferation data.
RESULTS
Host antibody reactivity to vector salivary proteins.To better
understand human anti-sand fly salivary antibody presence
based on differential exposure to wild P. papatasi sand flies,
six sites were selected as collection points for human host
peripheral blood samples. Each regional site, three sites
in Egypt and three sites in Jordan, was categorized into
different P. papatasi and leishmaniasis ecotopes (Table 1).
Additionally, US military personnel represented responses
by individuals immunologically naive to newly encountered
sand fly saliva. Plasma from a total of 111 Egyptian or
118 Jordanian residents and 69 USmilitary personnel was tested
against PAGE-separated SGS from inbred female P. papatasi
by Western immunoblot (Figure 1A and Supplemental Figure
2). Concurrently, PAGE-separated SGS revealed 11 heavily
expressed salivary proteins (~12, 14, 26, 28, 30, 38, 40, 42, 44,
46, and 58 kDa), with 1 modestly expressed protein of
~68 kDa (Figure 1B). Human donor blood plasma antibodies
displayed differential specificities for those proteins (Figure 1).
Images of immunoblots were scored by signal intensity of
plasma antibodies specific for P. papatasi salivary proteins at
each approximate molecular weight (MW). All final immuno-
blot scores at each MW for Egyptian and Jordanian donors
were compared with those scores of donors residing in control
regions, where no sand fly vectors were reported to be present.
US military donor scores were compared with those scores of
control donors who denied any travel to P. papatasi-endemic
regions. Antibody specificities for five salivary proteins (~12,
26, 30, 38, and 44 kDa) were found to be significantly dif-
ferent from control regions within one or both Middle East-
ern nations, whereas antibody specificity was significantly
different compared with the control group for only two salivary
proteins (~14 and 38 kDa) among Iraq-based US donors
infected with Leishmania (P < 0.05) (Table 2). Notably, among
Middle Eastern donors, there seemed to be very little, if any,
specificity for salivary proteins of ~15 or 21 kDa (data not
shown) and some minor differential recognition of an ~36 kDa
protein that was not observed to be a majorly expressed pro-
tein in the P. papatasi laboratory colony SGS (Figure 1B).
However, a salivary protein at ~14 kDa was significantly differ-
entially recognized by antibodies from US military donors.
Antibody specificity for salivary proteins can be summa-
rized using a novel calculation of immunogenicity (Figure 2).
Regarding Egyptian and Jordanian donors, plasma displayed
the greatest immunogenicity against salivary proteins at ~12,
30, and 38 kDa, regardless of geographic origin. Greater relative
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difference to control regions was more readily apparent among
plasma from Egyptian donors. Jordanian donor plasma from
Amman, a control region, exhibited much higher immunoge-
nicity to those three salivary proteins compared with donor
plasma from Cairo, the Egyptian control region (Figure 2 and
Table 1). This increased antibody specificity for three highly
immunogenic salivary proteins, in part, accounts for the lack of
statistical significance in testing differences between intrare-
gional profiles for Jordanian donors. The percentage of indi-
viduals reacting to the five significant salivary proteins was
greater among individuals residing in AW compared with MA
(Table 2). However, between NS and SW, the percent of per-
sons reacting to salivary proteins of ~12, 30, and 44 kDa was
similar, although more Egyptian donors displayed antibodies
against salivary proteins of ~26 and 38 kDa.
Considering the immunogenicity of salivary proteins to US
military donors, values for the ~38 kDa salivary protein were
substantially greater than those values of all other proteins
(Figure 2). Although 64% of bite-exposed individuals displayed
specificity for the ~26 kDa salivary protein (Table 2), signal
intensity and immunogenicity were not significantly different
from signal intensity and immunogenicity of control donor
plasma. Although the immunogenicity of an ~14 kDa protein
was low relative to the immunogenicity of an ~38 kDa protein, a
statistically significant difference between Leishmania-infected
donors and controls was found (P < 0.05, Student’s t test).
Table 2
Characteristics of salivary proteins with significant differences in host antibody specificity profiles
Salivary proteins (estimated MW)
12 kDa 26 kDa 30 kDa 38 kDa 44 kDa
MENA*
Percentage positive sera†
Egypt
CA (−/−) 43.24 27.03 37.84 45.95 8.11
AW (+/−) 90.00‡ 70.00‡ 90.00‡ 95.00‡ 42.50‡
NS (+/+) 79.41‡ 55.88‡ 88.24‡ 79.41‡ 41.18‡
Jordan
AM (−/−) 56.76 21.62 59.46 70.27 13.51
MA (+/−) 58.54 21.95 78.05‡ 73.17 12.20
SW (+/+) 77.50‡ 35.00 90.00‡ 60.00 45.00‡
Average blot intensity§
Egypt
CA (−/−) 0.51 ± 0.08 0.38 ± 0.13 0.62 ± 0.15 0.59 ± 0.12 0.14 ± 0.11
AW (+/−) 1.31 ± 0.15‡ 0.90 ± 0.11‡ 1.83 ± 0.16‡ 1.33 ± 0.11‡ 0.70 ± 0.12‡
NS (+/+) 1.26 ± 0.18‡ 0.96 ± 0.17‡ 2.09 ± 0.18‡ 1.38 ± 0.17‡ 0.84 ± 0.15‡
Jordan
AM (−/−) 0.66 ± 0.10 0.24 ± 0.14 0.86 ± 0.15 0.97 ± 0.08 0.22 ± 0.11
MA (+/−) 0.76 ± 0.06 0.29 ± 0.15 1.37 ± 0.16‡ 1.15 ± 0.10 0.13 ± 0.12
SW (+/+) 1.08 ± 0.14‡ 0.41 ± 0.15 1.53 ± 0.15‡ 0.94 ± 0.10 0.75 ± 0.12‡
Immunogenicity (a.u.)¶
Egypt
CA (−/−) 0.22 0.10 0.24 0.27 0.01
AW (+/−) 1.18‡ 0.63‡ 1.64‡ 1.26‡ 0.30‡
NS (+/+) 1.00‡ 0.53‡ 1.84‡ 1.10‡ 0.35‡
Jordan
AM (−/−) 0.38 0.05 0.51 0.68 0.03
MA (+/−) 0.44 0.06 1.07‡ 0.84 0.02
SW (+/+) 0.83‡ 0.14 1.37‡ 0.56 0.34‡
12 kDa 14 kDa 26 kDa 30 kDa 38 kDa
US military*
Percentage positive sera†
United States
Control 48.28 51.72 44.83 48.28 48.28
Bitten 23.53 52.94 64.71 29.41 76.47
Infected 34.78 13.04‡ 30.43 21.74 73.91‡
Average blot intensity§
United States
Control 0.52 ± 0.57 0.53 ± 0.53 0.50 ± 0.60 0.64 ± 0.77 0.48 ± 0.51
Bitten 0.24 ± 0.44 0.71 ± 0.85 0.74 ± 0.62 0.29 ± 0.47 1.00 ± 0.71
Infected 0.52 ± 0.85 0.30 ± 0.82‡ 0.48 ± 0.79 0.30 ± 0.70 1.70 ± 1.19‡
Immunogenicity (arbitrary units)¶
United States
Control 0.25 0.28 0.22 0.31 0.23
Bitten 0.06 0.37 0.48 0.09 0.76
Infected 0.18 0.04‡ 0.15 0.07 1.25‡
*Collection site abbreviations and conditional marks correspond to those abbreviations and marks presented in Table 1 (e.g., +/− refers to a region with known endemic P. papatasi populations
but no reports of L. major infections or for US military personnel, donor reported history of sand fly bites but there is no confirmed diagnoses of cutaneous leishmaniasis).
†Percentage of serum donors from the given location with antibody recognition of salivary proteins at the estimated MW.
‡Those regions with significant (P £ 0.05) differences in antibody reactivity compared with national negative control regions or US personnel who were not bitten by sand flies.
§Western immunoblots of human sera against P. papatasi SGS were scored manually by three independent observers using a scale: 0 = no reaction; 1 = weak reaction; 2 =moderate reaction;
3 = intense reaction (all judged relative to a constant positive control).
¶Immunogenicity here is calculated as (probability of donor serum antibody specificity to a particular salivary protein within a regional sample group) + (average band intensity among that
regional group) = a.u. of immunogenicity.
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Despite significant relative differences of raw immunoblot
scores to the control region for Egyptian donors, immunoge-
nicity values for salivary proteins at ~26 and 44 kDa were low
compared with those values of ~12, 30, and 38 kDa proteins.
Both the 26 and 44 kDa proteins were found in close relative
proximity to one or more proteins of similar MW (Figure 1B).
Because each donor plasma profile displayed differential spec-
ificity for majorly expressed salivary proteins, manual scoring
may have been imprecise for proteins at those two MWs.
Therefore, we took additional steps to more thoroughly char-
acterize both the majorly expressed salivary proteins and the
global single human donor plasma antibody specificity profiles.
Sand fly salivary protein identification. To more thoroughly
differentiate and characterize abundantly expressed P. papatasi
salivary proteins, 10 bands were excised from SGS segregated
by denaturing PAGE (~12, 14, 26, 28, 30, 38, 40, 42, 44, and
46 kDa). MS analyses were performed on the purified proteins
after trypsin digestion. Resultant spectra were compared
against all available NCBI protein database sequences for
Phlebotomus and Lutzomyia spp.33 Table 3 outlines the top
Figure 2. Immunogenicity to P. papatasi salivary gland proteins among plasma donors. (A) Immunogenicity of all P. papatasi salivary gland
proteins by Egyptian blood plasma donor antibody specificities from three regions (CA, AW, and NS) using consensus estimates of MW on
immunoblot images from three independent observers. (B) Immunogenicity of all P. papatasi salivary gland proteins by Jordanian blood plasma
donor antibody specificities from three regions (AM, MA, and SW). Ecological conditions in the regional key are the same as those conditions
outlined in Table 1. (C) Immunogenicity of all P. papatasi salivary gland proteins of Iraq-based US personnel and blood plasma donor antibody
specificities from individuals differentially exposed to sand fly bites andLeishmania parasites. Exposure criteria are the same as those criteria outlined
in Table 1. Immunogenicity is calculated as (probability of donor plasma antibody reaction of protein among a regional group) + (average of band
intensity among that regional group) = a.u. *Significant difference(s) in host plasma antibody specificity for protein(s) at theseMWs between sand fly-
endemic and control regional sites or between sand fly bite-exposed military personnel and unexposed control donors (P £ 0.05).
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protein matches, ordered by rank of best local match to our
database, for spectra of each protein band. All top-ranked
matches were against published protein sequences from the
P. papatasi Israeli colony strain. Despite seemingly clear and
unique in-gel MW differences for proteins in the 26 and 28 kDa
bands as well as those proteins in the 40, 42, 44, and 46 kDa
bands, multiple high-confidence protein matches were found
for each analyzed band. Moreover, given the high homology
in primary sequence for PpSP28 and PpSP30 (top matches for
the ~26 and 28 kDa bands) as well as between PpSP42 and
PpSP44 (top matches for the ~40, 42, 44, and 46 kDa bands),
identification was based predominantly on spectral matches to
domains exclusively unique to each protein. Within the range
of ~26–30 kDa, we distinguished three primary salivary pro-
teins that corresponded to differential donor antibody specific-
ities (Figure 1B), where MS matches to the ~26 and 28 kDa
proteins were equally confident between PpSP28 and PpSP30.
The band at ~30 kDamatched best to a 29 kDa salivary protein
precursor (gij76589378).
Clustering of host antibody anti-salivary protein profiles.
K-means clustering was performed on raw immunoblot score
data, and therefore, the complete global antibody specificity
profile for each individual donor was simultaneously considered.
This approach helped to better characterize the contribution
Table 3
Identification of majorly expressed P. papatasi salivary proteins by MS
P. papatasi salivary
protein (estimated
MW)*/rank Unused
Sequence
coverage† (%)
Accession
number Protein name Species
No. of unique
peptides
Confidence of
identification‡
Local FDR for
protein (%)
12 kDa
1 50.41 80 gi 15963505 12 kDa salivary protein precursor P. papatasi 56 ~> 1e-50 7e-5
2 25 57.8 gi 15963507 14 kDa salivary protein precursor P. papatasi 16 ~> 1e-25 7.3e-5
3 6 27.2 gi 15963515 32 kDa salivary protein precursor P. papatasi 4 ~> 1e-6 7.54e-5
4 5.56 55.3 gi 112497698 14.2 kDa salivary protein P. duboscqi 6 ~> 1e-5 7.66e-5
5 4 72.1 gi 112497317 13.7 kDa salivary protein P. duboscqi 22 ~> 1e-4 7.85e-5
6 2 30.5 gi 112497287 14.2 kDa salivary protein P. duboscqi 1 0.01 8.04e-5
14 kDa
1 33.3 86.1 gi 335954166 SP15 protein P. papatasi 50 ~> 1e-33 8.24e-5
2 11.18 86.1 gi 335954098 SP15 protein P. papatasi 44 ~> 1e-11 8.57e-5
3 6 28.2 gi 15963507 14 kDa salivary protein precursor P. papatasi 3 ~> 1e-6 8.66e-5
4 4.05 90.9 gi 112497496 14.5 kDa salivary protein P. duboscqi 39 ~> 1e-36 8.76e-5
5 4 10.6 gi 15963515 32 kDa salivary protein precursor P. papatasi 2 ~> 1e-4 8.86e-5
6 2 39.4 gi 112361953 14.4 kDa salivary protein P. duboscqi 3 0.01 9.05e-5
7 2 32.1 gi 157361529 40S ribosomal protein S12-like protein P. papatasi 1 0.01 9.05e-5
8 0.26 86.1 gi 335954106 SP15 protein P. papatasi 40 0.55 9.55e-5
26 kDa
1 30.74 71.3 gi 15963511 28 kDa salivary protein precursor P. papatasi 36 ~> 1e-30 8.78e-5
2 28.47 70 gi 15963513 30 kDa salivary protein precursor P. papatasi 40 ~> 1e-28 8.85e-5
28 kDa
1 30.78 57.5 gi 15963511 28 kDa salivary protein precursor P. papatasi 26 ~> 1e-30 4.69e-5
2 23.26 60.5 gi 15963513 30 kDa salivary protein precursor P. papatasi 18 ~> 1e-23 4.72e-5
30 kDa
1 28.72 56.3 gi 76589378 29 kDa salivary protein precursor P. papatasi 29 ~> 1e-28 9.06e-5
2 12 37.8 gi 15963515 32 kDa salivary protein precursor P. papatasi 8 ~> 1e-12 9.25e-5
38 kDa
1 113.02 92 gi 10443907 Salivary apyrase P. papatasi 114 ~> 1e-113 4.94e-5
2 6.06 74.1 gi 112496715 35.8 kDa salivary protein P. duboscqi 27 ~> 1e-6 5.21e-5
3 2.73 32 gi 299829440 32.9 kDa salivary protein P. sergenti 7 ~> 1e-3 5.31e-5
40 kDa
1 72.21 80.8 gi 15963517 42 kDa salivary protein precursor P. papatasi 70 ~> 1e-72 5.08e-5
2 9.68 51.1 gi 112497236 Yellow-related protein P. duboscqi 29 ~> 1e-9 5.15e-5
3 7.52 69.1 gi 10443907 Salivary apyrase P. papatasi 6 ~> 1e-72 5.24e-5
42 kDa
1 120.09 89.6 gi 15963517 42 kDa salivary protein precursor P. papatasi 110 ~> 1e-120 1.04e-3
2 21.3 73 gi 15963519 44 kDa salivary protein precursor P. papatasi 13 ~> 1e-21 1.09e-3
3 15.46 65.6 gi 112497236 Yellow-related protein P. duboscqi 46 ~> 1e-15 1.11e-3
4 4 55.2 gi 299829410 Yellow-related salivary protein P. duboscqi 19 ~> 1e-4 1.12e-3
44 kDa
1 91.06 85.8 gi 15963517 42 kDa salivary protein precursor P. papatasi 100 ~> 1e-90 6.72e-7
2 81.47 80.3 gi 15963519 44 kDa salivary protein precursor P. papatasi 97 ~> 1e-81 6.72e-7
3 15.45 61.8 gi 112497236 Yellow-related protein P. duboscqi 49 ~> 1e-15 6.75e-7
4 6.13 59.7 gi 112497202 Yellow-related protein P. duboscqi 41 ~> 1e-6 6.76e-7
46 kDa
1 130.07 98.3 gi 15963519 44 kDa salivary protein precursor P. papatasi 188 ~> 1e-130 1.1e-5
2 43.93 77.2 gi 15963517 42 kDa salivary protein precursor P. papatasi 41 ~> 1e-43 1.1e-5
3 8.89 74.7 gi 112497202 Yellow-related protein P. duboscqi 72 ~> 1e-8 1.11e-5
4 6.02 21.9 gi 76446619 Yellow-related salivary protein P. perniciosus 3 ~> 1e-6 1.12e-5
5 4.29 35.1 gi 10443907 Salivary apyrase P. papatasi 3 ~> 1e-4 1.12e-5
6 2.26 50.1 gi 112497236 Yellow-related protein P. duboscqi 26 ~> 1e-3 1.13e-5
7 2 38.7 gi 52001011 Yellow-related salivary protein P. papatasi 1 0.01 1.14e-5
*Based on denatured protein bands excised for MS analysis (Figure 1B).
†Percent representation of a protein based on unique peptide spectral assignments to that protein.
‡Negative log10 of the unused ProtScore, which is calculated using only peptides from spectra that have not been used by other proteins; a lower value indicates greater confidence of protein
identification-based additive assignments of unique peptides.
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that regional and ecological characteristics played on host-
acquired immunity to sand fly salivary proteins by
distinguishing common patterns within the large complex
dataset. K-means clustering was performed first with Egyptian
and Jordanian donor immunoblot data using k = 6 (one cluster
for each significant protein plus a null control) and again with
k = 5 (the number of significant proteins). No distinguishing or
consistently similar data patterns were observed using these
numbers of clusters (data not shown). However, on using k =
4 clusters (Supplemental Figure 3), data patterns emerged that
were both consistent among donors within each single cluster
and significantly divergent between clusters by cumulative
immunoblot intensity scores for the five immunogenic salivary
proteins (P < 0.05, Student’s t test). Similarly, in clustering
immunoblot data from the US military donors, the use of k =
4 clusters generated cluster profiles with distinct patterns of
specificity against the ~38, 30, 26, 14, and 12 kDa salivary
proteins (Supplemental Figure 4). Each cluster was also signif-
icantly divergent in this dataset by cumulative immunoblot
intensity scores for this different set of five distinguishing sali-
vary proteins (P < 0.05, Student’s t test). Table 4 outlines the
characteristic plasma antibody specificity patterns for each of
the five immunogenic salivary protein sets.
Clusters A–D pertain to Egyptian and Jordanian resident
datasets. Cluster A is a null response cluster (populated pre-
dominantly by control region donors). Cluster B is a cluster
with antibodies specific to ~12, 30, and 38 kDa salivary pro-
teins (minor difference between the numbers of donors from
each region). Cluster C is a cluster with predominant speci-
ficity to ~12, 30, 38 and 26 kDa proteins (again, no substan-
tial differences in regional donor numbers). Cluster D is a
cluster with specificity to ~12, 26, 30, 38, and 44 kDa salivary
proteins (substantially more donors residing in sand fly- and
leishmaniasis-endemic regions compared with controls). Only
the percentages of Egyptian CA and AW donors displayed a
significant inverse Pearson correlation across clusters (P <
0.05, r = −0.94). However, the percentages of donors from
both AW and NS trended positively across clusters, whereas
the percentages of CA donors trended negatively (Figure 3A).
For Jordanian donors, a significant positive correlation was
found between AM and MA donors across clusters (P < 0.05,
r = 0.96), and no correlations were observed between AM
and SW (Figure 3B). No correlations existed across clusters
between all donor immunoreactivity profiles combined by
ecotope (Figure 3C).
Clusters E–H pertain to the US military donor dataset.
Cluster E is a null response cluster (populated predominantly
by control region donors). Cluster F is a cluster with antibod-
ies specific almost exclusively to the ~38 kDa salivary protein
(a substantial difference in representation from each exposure
group, where the greatest percentage of individuals was from
the Leishmania-infected group). Cluster G is a cluster with
predominant specificity to ~14, 30, 26, and 38 kDa proteins
(again, a substantial difference in representation from each
exposure group, where the greatest percentage was from the
bitten but not infected group). Cluster H is a cluster with
specificity to ~12, 14, and 30 kDa salivary proteins (a cluster
populated largely of control donors). No statistically signifi-
cant correlations existed between exposure groups across
clusters E–H. The distribution of donors favored a single clus-
ter, where one anti-salivary gland protein specificity profile
was represented predominantly by donors of a single expo-
sure type group (Figure 3D).
Anti-SGS antibody isotype assessments. To further under-
stand the acquired antibody-based immunity to sand fly sali-
vary proteins, the six most representative donor plasmas from
each of the MENA regional resident study sites (associated
with each of the four k-means clusters) were assessed for
specific anti-SGS Ig isotype classifications (Figure 4 and Sup-
plemental Figure 5). Compared with concentrations for all
other antibody isotypes, significantly greater cumulative con-
centrations of anti-SGS IgG4 were present in donor plasma
(P < 0.05) (Figure 4). Notably, when data for all Ig isotypes
was analyzed cumulatively, a significant, albeit weak, positive
Pearson correlation was observed across the four clusters
(P = 0.01, r = 0.23). When each isotype was analyzed sepa-
rately, IgG1, −2, and −4 and IgE concentrations were positively
correlated across the clusters (P = 0.01–0.05, r = 0.42–0.54).
Only IgG3 did not correlate with clusters, likely as a result of
such low relative concentrations. These correlations logically
follow the defining characteristics of each cluster’s immuno-
reactivity profile, wherein progressively, there is greater spec-
ificity to more salivary proteins in clusters A–D. Evidence
exists for a correlation between anti-mosquito salivary IgG4
and IgE expression, which contributes to host type 1 hyper-
sensitivity.40 Here, anti-P. papatasi SGS IgG4 and IgE concen-
trations did correlate modestly (P = 0.02, r = 0.5). Whether
this correlation is actually related to the establishment of a
true hypersensitivity among donors residing in our ecotopes
of study remains unknown.
Cellular proliferation analysis. To assess donor cellular
responsiveness to P. papatasi salivary proteins, peripheral blood
mononuclear cells from a random subset of donors from each
regional location and exposure group were assessed in a prolif-
eration assay. Monocytic cells were adherence-selected from
cryopreserved donor leukocytes and differentiated to dendritic
cells by cytokine stimulation. Donor MDDCs were exposed to
SGS 1 day before coculture with remaining autogenic leuko-
cytes. Cellular proliferation between SGS pre-stimulated and
unstimulated cocultures was measured by incorporation of tri-
tiated thymidine (Figure 5). MDDCs of donors residing in sand
fly-endemic regions elicited, on average, less proliferation after
SGS exposure than those MDDCs from control region donors
(Figure 5A). However, only the stimulation ratios compared
between AM and MA site donors were significantly different
(Student’s t test, P < 0.05). Moreover, Iraq-deployed but unin-
fected US military donors exhibited less SGS-induced prolifer-
ation compared with control donors (Figure 5B).
Cytokine secretion profiles. To better understand cellular
sensitization of immunologically naı¨ve individuals to P. papatasi
Table 4
Principle salivary proteins in K-means clusters (estimated MW)
12 kDa 26 kDa 30 kDa 38 kDa 44 kDa
MENA clusters
A − − − − −
B + − + + −
C + + + + −
D + + + + +
US military clusters 12 kDa 14 kDa 26 kDa 30 kDa 38 kDa
E − − − − −
F − − − − +
G − + + + +
H + + − + −
Cluster characteristics are defined as antibody recognition at the listed protein MW for
> 50% of donors. Results details descriptions of clusters.
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salivary proteins, proliferation culture supernatants of Iraq-
based military donors exposed to SGS were analyzed to quan-
tify 21 secreted cytokine concentrations. Interleukin-8 (IL-8),
IL-17, and interferon-g–induced protein-10 (IP-10) of SGS-
stimulated donor cultures were significantly greater in the
supernatants of control exposure group donors than the super-
natants of cells from the Leishmania-infected donors (P < 0.05,
Student’s t test) (Figure 6).
DISCUSSION
We present here an examination of human host responses
to P. papatasi salivary proteins. The overarching goal of this
study was to understand the role of natural exposure to wild
sand flies by characterizing host-acquired immunity dynamics
with analyses of circulating antibody specificities and isotypes
to whole-sand fly SGSs as well as the memory response of
among leukocytes from those same donors. Together, these
data serve to further our understanding of host responses to
sand fly vector salivary proteins. Sites were selected in both
Egypt and Jordan by presumed differential exposure of resi-
dents to wild P. papatasi populations. In the context of human
antibody specificities against SGS proteins, a starker contrast
between ecotope sites was observed among Egyptian sites
compared with sites in Jordan (Figure 2A and B and Table 2).
All collection sites in Egypt were located farther apart from one
another compared with Jordanian collection sites (100+ miles
versus ~20 miles between sites, respectively), with far less
intersite human traffic. Such proximity and easier travel
throughout Jordan may be a factor contributing to SGS reac-
tivity of donors residing in control regions. However, in addi-
tion to potential donor travel to endemic P. papatasi regions,
the possibility of exposure to non-sand fly hematophagous
insects, generating antibodies with specificity to conserved pro-
tein domains, should not be discounted.41
Our data for MENA residents compare well with the data in
the work by Marzouki and others,12 which analyzed plasma
Figure 3. K-means clustering of total host plasma antibody specificity profiles to P. papatasi whole-salivary gland protein sonicates. Scores for
human host plasma specificity to sand fly salivary proteins were separated by national and ecological region groups and then clustered by the k-means
method across 1,000 iterations using Cluster v3.0, with k = 4 clusters and the Euclidean distance metric. (A) Total percentages of blood plasma donors
from each Egyptian regional site assigned to each anti-SGS antibody specificity profile cluster by k-means clustering. (B) Total percentages of blood
plasma donors from each Jordanian regional site assigned to each anti-SGS antibody specificity profile cluster by k-means clustering. (C) Total
percentages of blood plasma donors from combined regional sites (grouped by defining ecological characteristics) (Table 1) assigned to each anti-
SGS antibody specificity profile cluster by k-means clustering. (D) Total percentages of blood plasma donors from US military personnel differentially
exposed to sand fly bites and Leishmania parasites assigned to each anti-SGS antibody specificity profile cluster by k-means clustering. *K-means
cluster profile characteristics are outlined in Table 4. ‡A significant Pearson correlation was found between international donors from these sites.
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antibody specificity of Tunisian donors to P. papatasi salivary
proteins. Marzouki and others12 found that the majority of
their donors exhibited positive reactivity to salivary proteins at
~12, 15, 21, 28, 30, 36, and 44 kDa. Sand fly vectors in Tunisia
are phylogenetically distinct from sand flies endemic to Egypt,
Jordan, and Israel, which are part of a separate, albeit some-
what heterogeneous, population.42 The laboratory-reared
P. papatasi used in the present study originated from Israel.
Glycoinositolphospholipids (GIPLs) on the surface of
Trypanosoma spp. have been shown to alter the salivary pro-
file of their insect vector,43 invoking the possibility that cross-
strain variability among Leishmania spp. might affect vector
saliva profiles and consequently, change human host anti-
salivary protein antibody reactivity. Failure of Egyptian
and Jordanian donor plasma antibodies to recognize the sali-
vary protein at ~14 kDa (Figure 1), which was identified by
Marzouki and others,12 may be because of the differential
expression of this protein in distinct sand fly populations.
However, US military personnel exposed to sand fly bites in
Iraq displayed specificity to the protein at ~14 kDa. The fact
Figure 4. Isotyping of anti-SGS human host plasma antibodies. For each k-means cluster, six plasmas most representative of that k-means
cluster immunoreactivity profile and plasmas from individuals residing in each of the Middle Eastern regions were isotyped for total anti-SGS
antibodies using custom indirect ELISA. Individual donor results for each antibody isotype may be found in Supplemental Figure 5. *Clusters are
like those clusters described in Table 4. †Anti-SGS antibody concentrations were assessed by secondary antibody detection of a known concen-
tration of purified Ig isotype standards, plated in dilution series as primary antigen, and fitted to the resultant standard curve; final values were
averaged per cluster across all regional donors.
Figure 5. Mixed leukocyte proliferation in vitro of peripheral blood donors after stimulation of MDDCs with P. papatasi SGS. (A) Represen-
tative sampling of regional Egyptian and Jordanian resident donor cellular proliferations when exposed to SGS-stimulated autogeneic MDDCs.
Proliferation was measured using coculture with tritiated thymidine for 24 hours and b-particle decay counts per minute. Values presented are
ratios of stimulated over unstimulated assays normalized to a single positive control donor proliferation run concurrently. (B) Proliferation data
for US military personnel differentially exposed to sand fly bites and Leishmania parasites. *Significant differences by Student’s t test (P < 0.05).
#Stimulation index is the ratio of b-counts (3H-thymidine uptake) between unstimulated and SGS pre-stimulated MDDCs and mixed leuko-
cyte cocultures.
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that this previously naı¨ve group produced antibodies specific
to this protein and endemic residents did not highlights the
difference between chronic exposure to P. papatasi bites ver-
sus initial contact with new antigens in immunologically naive
persons. Indeed, the study by Marzouki and others12 used
blood samples collected from children between the ages of 6
and 12 years. The young age of donors in that study, likely
lacking the prolonged history of sand fly bite exposure
encountered by adult endemic residents in our current work,
may account for the differential specificities observed against
the ~14 kDa salivary protein. The fact that the immunogenic-
ity to this protein among US personnel was significantly less
within the Leishmania-infected donor group compared with
the sand fly bite only donors and controls suggests a possible
role of the parasite in diminishing host antibody production
against the ~14 kDa protein or a possible impact on sand fly
expression or post-translational modification of the protein
before host contact.
The lack of expression of an ~21 kDa protein (Figure 1B)
by our Israeli colony of P. papatasi could be because of differ-
ential salivary gene expression between variant vector popu-
lations, especially given the seasonal and regional differences
in expression of select salivary protein transcripts.15 Moreover,
differences in post-translational modifications of salivary pro-
teins, such as glycosylation or phosphorylation patterns,44
between the Tunisian and Israeli colonies may have led to
differences in protein identification and even antibody specific-
ities. Both studies used manual scoring of immunoblots, and
designations of positive specificities at particular MWs may not
be consistent between studies (i.e., what our observers agreed
was specificity at 26 and 38 kDa may have been, for Marzouki
and others12 observers, specificity at 28 and 36 kDa). It should
also be noted that Marzouki and others12 identify their linear-
ized 21 kDA salivary protein as PpSP42; we also identified this
protein, corresponding to linearized salivary proteins in the
~40–46 kDa range.
To assess the possible biological significance of immuno-
genic profile characteristics, P. papatasi salivary proteins were
identified by MS analysis. Proteins determined to be ~26 and
28 kDa by denaturing PAGE matched with approximately
equivalent coverage and confidence to PpSP28 and PpSP30.
The mature MWs for PpSP28 (gij15963511) and PpSP30
(gij15963513) are 27.2 and 27.8 kDa, respectively, and both
proteins share 82.1% primary sequence identity by pairwise
alignments, with multiple homologous domains. This infor-
mation suggests that immunoblot scores for proteins in the
26–28 kDa range may be for one or both proteins by cross-
immunoreactivity. PpSP28 and PpSP30 transcripts were dif-
ferentially expressed among wild-caught P. papatasi across
sites and time.15 Hence, exposure to sand fly bites at vari-
ous seasons throughout a year may influence global immune
responsiveness to P. papatasi. Although all blood samples from
the MENA region in this study were collected during a 3-week
window of late summer in 2007, circulating anti-salivary anti-
bodies may be a result of prior exposures. The functional pre-
dictions for PpSP28 and PpSP30 implicate their role in binding
thromboxane A,41 a host factor involved in vasoconstriction
and prothromobosis, a process that would be advantageous to
stifle the promotion of effective vector blood feeding.
Our results revealed that one majorly expressed salivary
protein of ~30 kDa is immunodominant to other salivary
proteins among MENA donors (Figure 2 and Table 2).
Figure 6. Secreted cytokines/chemokines of SGS-stimulated
MDDCs. Culture supernatant expression of (A) IL-8, (B) IL-17, and
(C) IP-10 secreted by in vitroMDDCs from differential sand fly- and
Leishmania-exposed US military personnel blood donors after stimu-
lation with SGS. *Data are MFI + SD after normalization of SGS-
stimulated MDDC supernatants to paired unstimulated supernatant
values. **Significant differences by Student’s t test (P < 0.05).
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Another report implicated a ~30 kDa salivary protein as
strongly immunodominant,13 and Marzouki and others11
recently postulated that the strongest degree of antibody spec-
ificity among pre-exposed human and murine hosts was against
a 32 kDa P. papatasi salivary protein (PpSP32, gij15963515).
We analyzed an SGS protein band of approximately the same
MW by MS (Figure 1B). The best match from among all pub-
lished phlebotomine sand fly protein sequences33 was PpSP29
(gij76589378) (Table 2). PpSP32 emerged as a secondary
match for the same protein gel band. PpSP29 and PpSP32
share little homology between primary sequences by pair-
wise alignment (data not shown). Most P. papatasi protein
sequences in our local database were those sequences pub-
lished from work with the Israeli colony, the same colony
used throughout our study. Marzouki and others12 performed
experiments using a Tunisian strain of P. papatasi but per-
formed identifications using the same approximate database
of protein sequences. It follows logically that our MS analysis
yielded matches with higher degrees of confidence compared
with the study by Marzouki and others,12 which used a pop-
ulation of differential phylogenetic origin42 from the com-
mon protein database. Abdeladhim and others41 recently
performed an exhaustive analysis of the Tunisian strain
P. papatasi salivary proteome through translated Basic Local
Alignment Search Tool (BLAST) alignments of RNA tran-
scripts to the same common protein sequence database.
PpSP29 was found to display homology to insect allergen
5 (AG5), a protein expressed in most hematophagous insects.
Immunoreactivity to PpSP29, given its membership in the pan-
vector AG5 protein family, could be generated by exposure to
other insect vectors because of conserved immunogenic epi-
topes. PpSP32 was predicted to be a potential mucin based on
similarities of glycosylation sites and thus far, has been shown
to be exclusively produced by sand flies.45 Exposure to mucin-
like PpSP32 might stimulate T-cell proliferation and cytokine
production, which has been known to occur in response to
other true mucins.46 Given the agreed importance of proteins
at the 30-kDa range, future analysis using recombinant
PpSP29 and PpSP32 will be beneficial to ascertain which pro-
tein is the true immunodominant salivary antigen.
Conversely, for Iraq-based US military donors, the most
immunodominant P. papatasi salivary protein was one of
~38 kDa (Figure 2 and Table 2). Marzouki and others11,12 also
noted that Tunisian donor antibodies displayed high specific-
ity to this protein (referred to as an ~36 kDa protein) but not
the same degree as the ~30/32 kDa protein(s). The ~38 kDa
protein matched best to a salivary apyrase (gij10443907).
Apyrases hydrolyze both adenosine triphosphate (ATP) and
adenosine diphosphate (ADP) to adenosine monophosphate
(AMP), thus destroying an important physiologic stimulus of
host platelet aggregation released from damaged tissues and
blood cells. Apyrases have been found in most every hema-
tophagous arthropod.47 The stark dichotomy between two
donor groups (presumably chronically exposed regional resi-
dents and previously immunologically naive US military) in
terms of reactivity to the ~30 and 38 kDa proteins may
suggest a population scale-acquired immune specificity for a
protein that could be more specific to the Phelobotomus
genus (~30 kDa), versus one that is more encountered from
insect bites occurring in the United States (~38 kDa), or at
least to which immunologically naive individuals more readily
produce antibodies against after initial exposures.
We used k-means clustering to identify patterns of plasma
antibody immunoreactivity to SGS proteins across donors.
Antibody specificity to the five salivary proteins that elicited
significantly different immunoreactivity among MENA-
endemic donors compared with control region data was the
principle factor distinguishing clusters A–D (Table 4 and Sup-
plemental Figure 3). Among Egyptian donors, CA and AW
displayed a significant inverse Pearson correlation across clus-
ters (P < 0.05, r = −0.94). No significant inverse correlation
was observed between CA and NS, despite an inverse trend
(Figure 3A). For Jordanian donors, a significant positive cor-
relation was found between AM and MA donors across clus-
ters (P < 0.05, r = 0.96), and no correlations were observed
between AM and SW (Figure 3B). The shorter intersite dis-
tances and increased travel of residents in Jordan may have
led to more homogeneous exposure conditions compared
with the more distant and isolated Egyptian sites, accounting
for the negative correlations in Jordan between control and
exposure sites. Donors with strong immunoreactivity to the
~12 and 38 kDa salivary proteins also displayed significant
antibody specificity for the ~30 kDa immunodominant pro-
tein. The concurrent presence of plasma antibodies to all
proteins in these three MW ranges was the defining factor
differentiating k-means clusters A from B (Table 4). By
extension, immunoreactivity to all three salivary proteins
(but not any one protein or pair of proteins) differentiated
donors residing mostly in control regions from those donors
residing in regions with endemic P. papatasi populations. Our
data showed that immense antibody specificity to the ~12 kDa
protein (but not the ~14 kDa protein) was present among
many donors. Although the function of both proteins remains
unknown, the differences in immunoreactivity could suggest
divergent functions or expression patterns or differential anti-
body specificity caused by glycosylation. Given the conserved
pan-vector expression of the ~38 kDa salivary protein, the
bloodfeeding function of proteins in the ~30-kDa range, and
the high degree of immunoreactivity to the ~12 kDa protein,
future investigations of sand fly salivary proteins should con-
sider proteins in these three ranges in combination.
The same parameters used to cluster MENA immunoblot
scores were used with US military personnel data. Although
only two salivary proteins displayed immunogenicity signifi-
cantly different between Leishmania-infected donors and
unexposed controls (~14 and 38 kDa), again, antibody speci-
ficity for five proteins was the defining characteristic for clus-
ters E–H (Table 4 and Supplemental Figure 4). Like the
MENA regional donor data, cumulative immunoblot scores
for the five proteins (~12, 14, 26, 30, and 38 kDa) were sig-
nificantly different among donor members of each cluster
(P < 0.05, Student’s t test). The absence of specificity for
proteins ~44 kDa, the emergence of significantly differential
specificity to the ~14 kDa protein, and the apparent immuno-
dominance of the ~38 kDa protein (immunoreactivity to this
protein alone defined the profile of cluster F) were key ele-
ments that defined the differences in profiles between US
military donors and Egyptian or Jordanian donors. When
assessing the exposure characteristics of donors in each of clus-
ters E–H, the simple majority of Leishmania-infected donors
made up the individuals grouped into cluster F, whereas cluster
G was populated mostly by individuals who were bitten by
sand flies but not infected (Figure 3D). Because cluster F is
characterized by the singular specificity to the ~38 kDa salivary
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protein, the average signal intensity of Leishmania-infected
donors in that cluster to that protein was substantially greater
than the average signal intensity of the bite exposure-only
donors (2.2 versus 1.2, respectively). The same intracluster
characteristics were true between donors of both groups in
cluster G. Notably, the cluster with the greatest percentage of
unexposed control donors was cluster H, characterized by anti-
body specificity for ~12, 14, and 30 kDa salivary proteins. Spec-
ificity for the ~30 kDa protein occurred in > 50% of all donors
in this cluster H, but among unexposed control donors
grouped into the cluster, the split was an even 50:50, making
immunoreactivity to that protein a potentially conditional
criteria for cluster definition (Supplemental Figure 2). The
dominance of the ~12 and 14 kDa protein specificity among
control donors may suggest that it is these proteins that
donors produce from circulating antibodies as a result of expo-
sure to other hematophagous arthropods or that these proteins
exhibit some post-translational modification to offer epitopes
against which unexposed individuals have normal circulat-
ing antibodies.
Four majorly expressed proteins, ~40, 42, 44, and 46 kDa,
all matched with high coverage and confidence to either
PpSP42 or PpSP44 (Table 3). Both proteins share 84.1% pri-
mary sequence homology and resemble yellow-related pro-
teins, like those proteins found in L. longipalpis that function
as antiinflammatory factors on dendritic cells.48 Because anti-
body specificities to both the ~26 and 44 kDa proteins were
differentiating characteristics betweenmultiple k-means clusters
among MENA donors (Table 4 and Supplemental Figure 3),
the expression of such proteins in sand flies could occur in a
conditional manner to elicit differential host responses.
Despite that our data indicate the ~26 and 44 kDa protein(s)
to be less immunogenic than the other three major salivary
proteins (Figure 2A and B and Table 2), the proposed func-
tions and status in differentiating immunoreactivity clusters
make the case for additional investigation of these proteins
as combinatorial diagnostic markers of sand fly exposure.
Enzyme-linked immunosorbent assays (ELISAs) revealed
that the dominant isotype and subclass of circulating anti-SGS
antibodies is IgG4. Positive correlations were observed across
k-means clusters for IgG1, −2, and −4 and IgE isotypes. We
also observed a positive correlation between concentrations
of IgG4 and IgE across clusters (P = 0.02, r = 0.5) (Figure 4).
IgG4 and IgE are generalized as markers of Th2 immunity
bias and allergenic type 1 hypersensitivity, respectively. The
correlation between both antibody isotypes agrees with prior
reports, where IgE production is dependent on Th2 responses
and often associated with concurrent IgG4 production.49,50
Hence, because donors displayed circulating anti-SGS anti-
body profiles with progressive immunoreactivity for all five of
the major salivary proteins (Table 2), a possibility emerged
that allergic reactions to sand fly saliva could be part of the
global host immunological response dictated by additive
responses to those five proteins. These data further emphasize
the notion that achieving acquired immunity to sand fly saliva
may be the product of concurrent responses to multiple sali-
vary proteins.
To broadly examine acquired cellular immunity, we moni-
tored proliferation of donor leukocytes cocultured with auto-
geneic monocyte-derived dendritic cells pre-exposed to SGS.
Using a random subset of MENA donor samples, we
observed a trend to diminished cellular proliferation among
donors from P. papatasi-endemic regions compared with
those donors residing in control areas (Figure 5A), an obser-
vation similar to the observation by Rohousova and others.51
Despite the fact that the only proliferative responses between
AM and MA were significantly different by Student’s t test
(P < 0.05), the trending patterns among both Jordanian and
Egyptian donors would suggest that donors residing in regions
with P. papatasi populations elicit a mitigated proliferative
response on reexposure to sand fly saliva compared with
unexposed donors. In similar fashion, MDDCs from Iraq-
based military personnel donors bitten by sand flies but not
infected with Leishmania induced significantly less cellular
proliferation compared with unexposed donors (Figure 5B).
A recent report52 showed that CD4+ T cells from sand fly-
exposed humans stimulated with SGS expressed high levels of
IFN-g. When CD8+ T cells from the same donors were stimu-
lated with SGS, high amounts of IL-10 were produced. When
both cell types were cocultured and SGS was stimulated, only
IL-10 was predominantly produced. However, when IL-10
was blocked during stimulation, cellular proliferation was
substantially increased. The imbalance of Th1 and Th2 phe-
notypes at the lymphocyte point of response may also explain
our observations in addition to potential reprogramming of
antigen-presenting cells. Moreover, another report showed
that P. papatasi saliva inhibited the function of murine den-
dritic cells in mice through increasing concentrations of free
adenosine nucleosides and AMP.53 With the presence of
the ~38 kDa apyrase in our SGS, it may be possible that
increased hydrolytic reactions by that protein to boost AMP
levels in dendritic cell cultures could stymie the proliferative
responses of subsequent mixed leukocyte cultures. No signif-
icant differences in stimulation indexes were observed when
donors were grouped according to cluster membership (data
not shown). Thus, although distinctive immunoreactivity
profiles may allude to the biological activity induced by dif-
ferential exposure characteristics, those same profiles do not
seem to dictate overall MDDC licensing of immune responses
on reexposure.
Culture supernatants from SGS-stimulated US military per-
sonnel donors were used to assess the production of secreted
cytokines and chemokines. The significant difference in total
cellular proliferation between control and sand fly bite-
exposed donors suggested the likelihood of differential cell
signaling profiles to drive or inhibit that response. Leishmania-
infected donors produced significantly less secreted IL-8,
IL-17, and IP-10 compared with unexposed control donors
(P < 0.05, Student’s t test) (Figure 6). IL-17 is a major proin-
flammatory signaling molecule in the context of cutaneous
leishmaniasis infections shown to promote cutaneous disease
progression and severity in the BALB/c mouse model.54 Bone
marrow-derived dendritic cells pre-exposed to salivary gland
extracts from the South American Leishmania sand fly vector
L. longipalpis exhibited diminished IL-17 expression when sec-
ondarily challenged to inflammation.48 Moreover, peripheral
blood mononuclear cells from human donors who self-healed
from cutaneous disease expressed less IL-17 compared with
individuals presenting with active disease after in vitro rechal-
lenge with soluble Leishmania antigens.55 IL-8 and IP-10
(CXCL10) are potent chemotactic agents responsible for
recruitment of neutrophils, monocytes, and other immune cell
types and have been shown to be responsible for the abroga-
tion of the visceral forms of leishmaniasis.56 Pre-exposure of
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murine cells to L. intermedia salivary sonicates resulted
in decreased IP-10 expression during subsequent secondary
exposures.57 The combination of both sand fly salivary protein
and Leishmania parasite exposure may have generated immu-
nological memory sufficient to significantly decrease the
relative expression of IL-17, IL-8, and IP-10 after challenge
with P. papatasi saliva alone.
Taken together, it seems that, as investigations go forward
to identify vaccine candidates from the saliva of sand flies, a
combinatorial approach will likely be necessary. Indeed,
stronger immune responses are evident in hosts pre-exposed
to homogenous laboratory colony strains of P. papatasi than
heterogeneous wild populations,58,59 with protein polymor-
phisms implicated as a possible explanation for the phenom-
ena; this finding further emphasizes the need for development
of a clear universal baseline profile for host-acquired immu-
nity to vector salivary components.
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